Paolo Morgese Joins Alira Health

Alira Health welcomes Paolo Morgese as Vice President, Market Access

Paolo will lead the market access activities for Alira Health and manage the new office location in Geneva, Switzerland.

GENEVA, SWITZERLAND – MAY, 22, 2019 – Alira Health (, a leading international healthcare and life sciences advisory firm, announced that Paolo Morgese has joined the firm as Vice President, Market Access.

“Paolo brings deep expertise in market access in Europe, especially in gene and cell therapy and in oncology in general”, says Benjamin Chambon, Alira Health’s Chief Operating Officer.

“I have always had a high opinion of Alira Health’s expertise. Its focus on areas at the crossroads between clinical development, access to market, and investment fits well with my expertise and together we will be able to bring incredible value to our clients”, says Paolo.

Paolo Morgese joined Alira Health in May 2019 and leads a new office in the campus biotech innovation park based in Geneva, Switzerland. Alira Health now includes five offices in Europe and two in the U.S.

Abut Paolo Morgese:

Paolo Morgese brings over 15 years of expertise in market access and pricing.

After working at health technology assessment agency Kyphon, and with Merck Serono in health economics and market access roles, Paolo joined the healthcare investment fund Deerfield Management as EU Director of Research in 2012. He set up market access research activities and led the European Equity Research team during his five-year tenure.

In 2017, Paolo founded Forethought Access, a boutique market access consultancy focusing on early-stage market access in relation to financing/investment activities.

Paolo holds the position of EU Director of Market Access at the Alliance for Regenerative Medicine and is a recognized expert on market access of Advanced Therapies. ​

Paolo holds a Laurea in Economics from the University of Siena (IT) and MSc in Financial and Business Economics from the University of Essex (UK).

To the more about the Alira Health team, please visit: